Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Rules - 2013

Rules - 2013

Applications for Exempt Chemical Preparations

Order With Opportunity for Comment: Exempt Chemical Preparations Under the Controlled Substances Act (July 3, 2013)

Order With Opportunity for Comment: Exempt Chemical Preparations Under the Controlled Substances Act (January 22, 2013)

Drug Scheduling Actions

Final Rule: Placement of Perampanel into Schedule III (December 2, 2013)

Final Order: Temporary Placement of Three Synthetic Phenethylamines Into Schedule I (November 15, 2013)

Proposed Rule: Placement of Tramadol Into Schedule IV (November 4, 2013)

Proposed Rule: Placement of Perampanel into Schedule III (October 22, 2013)

Notice of Intent: Temporary Placement of Three Synthetic Phenethylamines Into Schedule I (October 10, 2013)

Final Order: Temporary Placement of Three Synthetic Cannabinoids Into Schedule I (May 16, 2013)

Final Rule: Placement of Lorcaserin Into Schedule IV (May 8, 2013)

Notice of Intent: Temporary Placement of Three Synthetic Cannabinoids Into Schedule I (April 12, 2013)

Final Rule: Placement of Methylone Into Schedule I (April 12, 2013)

Proposed Rule: Placement of Alfaxalone into Schedule IV (March 25, 2013)

Final Rule: Establishment of Drug Codes for 26 Substances (January 4, 2013)

Electronic Prescriptions for Controlled Substances

Notice of Approved Certification Process: Electronic Prescriptions for Controlled Substances (March 26, 2013)

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Printing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility